Sergey S. Zhokhov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sergey S. Zhokhov has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Alexander A. Makarov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
6 shared publications - Ivan A. Andreev
N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences Moscow 119991 Russia
6 shared publications - Nina K. Ratmanova
Department of Chemistry, M. V. Lomonosov Moscow State University, Leninskie gory 1-3, Moscow 119991, Russia
6 shared publications - Olga Alexandrovna Ivanova
Department of Chemistry, M. V. Lomonosov Moscow State University, Leninskie gory 1-3, Moscow 119991, Russia
6 shared publications - Sergey A. Kozin
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia
6 shared publications - Vladimir Alexandrovich Mitkevich
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
6 shared publications
Latest Publications
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
Competition between charge and orbital control governs the divergent reactivity of hydrazines toward donor–acceptor cyclopropanes
Substituted hydrazines were successfully applied as ambident partners to prepare pyridazin-3-ones via 6-ring closure with arylhydrazines and 1-aminopyrrolidin-2-ones by 5-membered ring formation with hydrazines bearing electron-withdrawing groups.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
Competition between charge and orbital control governs the divergent reactivity of hydrazines toward donor–acceptor cyclopropanes
Substituted hydrazines were successfully applied as ambident partners to prepare pyridazin-3-ones via 6-ring closure with arylhydrazines and 1-aminopyrrolidin-2-ones by 5-membered ring formation with hydrazines bearing electron-withdrawing groups.
- 1 December 2025
- Published by Wiley in Angewandte Chemie
- Vol. 138 (12)
Coumarin‐30 Enables Site‐Resolved Detection of Tubulin Ligands by Microscale Thermophoresis
Tubulins are among the most successful targets for cancer chemotherapy. However, the emergence of drug resistance stimulates the continuous search for novel chemotherapeutics. We discovered that coumarin‐30, a widely available laser dye, binds to the colchicine site of tubulin, inhibiting microtubule dynamics and cancer cell division at submicromolar concentrations. Exploiting the excellent fluorescent properties of coumarin‐30, we developed a fast, accurate, and cost‐effective coumarin‐30‐based microscale thermophoresis (C‐MST) assay as an express method for detecting tubulin–ligand interactions and discriminating colchicine site binders from ligands targeting other protein pockets. Using this assay, we identified several potent tubulin polymerization inhibitors associating with the colchicine site and validated them through in vitro microtubule dynamics and cell cycle assays in cancer cells. Furthermore, the C‐MST assay was demonstrated to detect ligands targeting a novel binding site on tubulin, recently established through crystallographic fragment screening. We confirmed detection of a small‐molecule ligand targeting that site and further designed and characterized a series of its analogs. The ability of the C‐MST assay to detect tubulin binders regardless of their binding site or their effect on microtubule dynamics opens new avenues for developing unconventional modulators of tubulin–tubulin and tubulin–effector interactions thereby facilitating anticancer drug discovery.
- 1 December 2025
- Published by Wiley in Angewandte Chemie
- Vol. 138 (12)
Coumarin‐30 Enables Site‐Resolved Detection of Tubulin Ligands by Microscale Thermophoresis
Tubulins are among the most successful targets for cancer chemotherapy. However, the emergence of drug resistance stimulates the continuous search for novel chemotherapeutics. We discovered that coumarin‐30, a widely available laser dye, binds to the colchicine site of tubulin, inhibiting microtubule dynamics and cancer cell division at submicromolar concentrations. Exploiting the excellent fluorescent properties of coumarin‐30, we developed a fast, accurate, and cost‐effective coumarin‐30‐based microscale thermophoresis (C‐MST) assay as an express method for detecting tubulin–ligand interactions and discriminating colchicine site binders from ligands targeting other protein pockets. Using this assay, we identified several potent tubulin polymerization inhibitors associating with the colchicine site and validated them through in vitro microtubule dynamics and cell cycle assays in cancer cells. Furthermore, the C‐MST assay was demonstrated to detect ligands targeting a novel binding site on tubulin, recently established through crystallographic fragment screening. We confirmed detection of a small‐molecule ligand targeting that site and further designed and characterized a series of its analogs. The ability of the C‐MST assay to detect tubulin binders regardless of their binding site or their effect on microtubule dynamics opens new avenues for developing unconventional modulators of tubulin–tubulin and tubulin–effector interactions thereby facilitating anticancer drug discovery.
- 1 December 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (12) , e17086
Coumarin‐30 Enables Site‐Resolved Detection of Tubulin Ligands by Microscale Thermophoresis
Tubulins are among the most successful targets for cancer chemotherapy. However, the emergence of drug resistance stimulates the continuous search for novel chemotherapeutics. We discovered that coumarin‐30, a widely available laser dye, binds to the colchicine site of tubulin, inhibiting microtubule dynamics and cancer cell division at submicromolar concentrations. Exploiting the excellent fluorescent properties of coumarin‐30, we developed a fast, accurate, and cost‐effective coumarin‐30‐based microscale thermophoresis (C‐MST) assay as an express method for detecting tubulin–ligand interactions and discriminating colchicine site binders from ligands targeting other protein pockets. Using this assay, we identified several potent tubulin polymerization inhibitors associating with the colchicine site and validated them through in vitro microtubule dynamics and cell cycle assays in cancer cells. Furthermore, the C‐MST assay was demonstrated to detect ligands targeting a novel binding site on tubulin, recently established through crystallographic fragment screening. We confirmed detection of a small‐molecule ligand targeting that site and further designed and characterized a series of its analogs. The ability of the C‐MST assay to detect tubulin binders regardless of their binding site or their effect on microtubule dynamics opens new avenues for developing unconventional modulators of tubulin–tubulin and tubulin–effector interactions thereby facilitating anticancer drug discovery.
- 1 December 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (12) , e17086
Coumarin‐30 Enables Site‐Resolved Detection of Tubulin Ligands by Microscale Thermophoresis
Tubulins are among the most successful targets for cancer chemotherapy. However, the emergence of drug resistance stimulates the continuous search for novel chemotherapeutics. We discovered that coumarin‐30, a widely available laser dye, binds to the colchicine site of tubulin, inhibiting microtubule dynamics and cancer cell division at submicromolar concentrations. Exploiting the excellent fluorescent properties of coumarin‐30, we developed a fast, accurate, and cost‐effective coumarin‐30‐based microscale thermophoresis (C‐MST) assay as an express method for detecting tubulin–ligand interactions and discriminating colchicine site binders from ligands targeting other protein pockets. Using this assay, we identified several potent tubulin polymerization inhibitors associating with the colchicine site and validated them through in vitro microtubule dynamics and cell cycle assays in cancer cells. Furthermore, the C‐MST assay was demonstrated to detect ligands targeting a novel binding site on tubulin, recently established through crystallographic fragment screening. We confirmed detection of a small‐molecule ligand targeting that site and further designed and characterized a series of its analogs. The ability of the C‐MST assay to detect tubulin binders regardless of their binding site or their effect on microtubule dynamics opens new avenues for developing unconventional modulators of tubulin–tubulin and tubulin–effector interactions thereby facilitating anticancer drug discovery.
- Open Access
- 29 September 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 12 (24) , 6852-6863
New mode of sulfur ylides reactivity: stereoelectronic control provides C–C bond insertion before cyclopropanation/epoxidation directly affording homologated three-membered rings
Sulfur ylides enable a stereoelectronically-assisted C–C bond insertion followed by Corey–Chaykovsky cyclopropanation or epoxidation, allowing for dual CH 2 transfer to alkenes and aldehydes.
- 29 September 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 12 (24) , 6852-6863
Open AccessNew mode of sulfur ylides reactivity: stereoelectronic control provides C–C bond insertion before cyclopropanation/epoxidation directly affording homologated three-membered rings
Sulfur ylides enable a stereoelectronically-assisted C–C bond insertion followed by Corey–Chaykovsky cyclopropanation or epoxidation, allowing for dual CH 2 transfer to alkenes and aldehydes.
- 15 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (1) , 274-285
Synthesis and evaluation of tetrahydropyrrolo[1,2- a ]quinolin-1(2 H )-ones as new tubulin polymerization inhibitors
New 1,5-disubstituted pyrrolidin-2-ones 1, 2 and 5-aryl-3,3 a ,4,5-tetrahydropyrrolo[1,2- a ]quinoline-1(2 H )-ones 3 were explored as inhibitors of tubulin polymerization.
- 15 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (1) , 274-285
Synthesis and evaluation of tetrahydropyrrolo[1,2- a ]quinolin-1(2 H )-ones as new tubulin polymerization inhibitors
New 1,5-disubstituted pyrrolidin-2-ones 1, 2 and 5-aryl-3,3 a ,4,5-tetrahydropyrrolo[1,2- a ]quinoline-1(2 H )-ones 3 were explored as inhibitors of tubulin polymerization.
- Open Access
- 10 July 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (44) , 26022-26033
The impact of alicyclic substituents on the extraction ability of new family of 1,10-phenanthroline-2,9-diamides
Development of efficient extractants for the separation of actinides and lanthanides in the technologies of nuclear fuel cycle is one of the most urgent and complex tasks in modern nuclear energetics. New family of 4,7-dichloro-1,10-phenanthroline-2,9-dicarboxylic acid diamides based on cyclic amines was synthesized and shown to exhibit high selectivity in the La/Am pair separation (SF (Am/La ≈ 10)) and in the Am/Eu pair separation (SF (Am/Eu ≈ 12)). It was shown that pyrrolidine derived diamide is more efficient extractant for americium, curium and lanthanides from highly acidic HNO3 solution than its non-cyclic N,N,N′,N′-tetraalkyl analogues. The structures of synthesized compounds were studied in details by IR, NMR spectroscopy, and single crystal X-ray diffraction. According to spectroscopy data, incorporation of aromatic rings to the amide fragment of ligand leads to complex dynamic behavior in solutions what is believed to strongly affect the extraction ability of synthesized ligands.
- 10 July 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (44) , 26022-26033
Open AccessThe impact of alicyclic substituents on the extraction ability of new family of 1,10-phenanthroline-2,9-diamides
Development of efficient extractants for the separation of actinides and lanthanides in the technologies of nuclear fuel cycle is one of the most urgent and complex tasks in modern nuclear energetics. New family of 4,7-dichloro-1,10-phenanthroline-2,9-dicarboxylic acid diamides based on cyclic amines was synthesized and shown to exhibit high selectivity in the La/Am pair separation (SF (Am/La ≈ 10)) and in the Am/Eu pair separation (SF (Am/Eu ≈ 12)). It was shown that pyrrolidine derived diamide is more efficient extractant for americium, curium and lanthanides from highly acidic HNO3 solution than its non-cyclic N,N,N′,N′-tetraalkyl analogues. The structures of synthesized compounds were studied in details by IR, NMR spectroscopy, and single crystal X-ray diffraction. According to spectroscopy data, incorporation of aromatic rings to the amide fragment of ligand leads to complex dynamic behavior in solutions what is believed to strongly affect the extraction ability of synthesized ligands.
- 15 September 2017
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 56 (39)
Frontispiece: A Binuclear Zinc Interaction Fold Discovered in the Homodimer of Alzheimer's Amyloid‐β Fragment with Taiwanese Mutation D7H
- 15 September 2017
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 56 (39)
Frontispiece: A Binuclear Zinc Interaction Fold Discovered in the Homodimer of Alzheimer's Amyloid‐β Fragment with Taiwanese Mutation D7H
- 15 September 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (39)
Frontispiz: A Binuclear Zinc Interaction Fold Discovered in the Homodimer of Alzheimer's Amyloid‐β Fragment with Taiwanese Mutation D7H
- 15 September 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (39)
Frontispiz: A Binuclear Zinc Interaction Fold Discovered in the Homodimer of Alzheimer's Amyloid‐β Fragment with Taiwanese Mutation D7H
- 27 June 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (39) , 11896-11901
A Binuclear Zinc Interaction Fold Discovered in the Homodimer of Alzheimer's Amyloid‐β Fragment with Taiwanese Mutation D7H
Zinc‐induced oligomerization of amyloid‐β peptide (Aβ) produces potentially pathogenic agents of Alzheimer's disease. Mutations and modifications in the metal binding domain 1–16 of Aβ peptide crucially affect its zinc‐induced oligomerization by changing intermolecular zinc mediated interface. The 3D structure of this interface appearing in a range of Aβ species is a prospective drug target for disease modifying therapy. Using NMR spectroscopy, EXAFS spectroscopy, mass spectrometry, and isothermal titration calorimetry the interaction of zinc ions with Aβ fragments 1–7 and 1–10 carrying familial Taiwanese mutation D7H was studied. Zinc ions induce formation of a stable homodimer formed by the two peptide chains fastened by two zinc ions and stacking interactions of imidazole rings. A binuclear zinc interaction fold in the dimer structure was discovered. It can be used for designing zinc‐regulated proteins and zinc‐mediated self‐assembling peptides.
- 27 June 2017
- Published by Wiley in Angewandte Chemie
- Vol. 129 (39) , 11896-11901
A Binuclear Zinc Interaction Fold Discovered in the Homodimer of Alzheimer's Amyloid‐β Fragment with Taiwanese Mutation D7H
Zinc‐induced oligomerization of amyloid‐β peptide (Aβ) produces potentially pathogenic agents of Alzheimer's disease. Mutations and modifications in the metal binding domain 1–16 of Aβ peptide crucially affect its zinc‐induced oligomerization by changing intermolecular zinc mediated interface. The 3D structure of this interface appearing in a range of Aβ species is a prospective drug target for disease modifying therapy. Using NMR spectroscopy, EXAFS spectroscopy, mass spectrometry, and isothermal titration calorimetry the interaction of zinc ions with Aβ fragments 1–7 and 1–10 carrying familial Taiwanese mutation D7H was studied. Zinc ions induce formation of a stable homodimer formed by the two peptide chains fastened by two zinc ions and stacking interactions of imidazole rings. A binuclear zinc interaction fold in the dimer structure was discovered. It can be used for designing zinc‐regulated proteins and zinc‐mediated self‐assembling peptides.